Direct-to-Patient Programs in Pharmaceuticals

This research report discusses the trends and developments related to Direct-to-Patient (DTP) programs in the pharmaceutical industry. It outlines the widespread adoption of these programs, highlighting their role in enhancing patient experience and access to healthcare. The report details the current services offered by DTP initiatives, such as telehealth, digital pharmacy fulfillment, and payment support. It also presents survey findings indicating that a significant percentage of pharmaceutical manufacturers are either running or planning to launch DTP programs. Furthermore, the report identifies barriers to implementing DTP programs, including budget limitations and compliance concerns. It emphasizes the importance of DTP programs in improving patient adherence and engagement while addressing the challenges faced by pharmaceutical companies in this evolving landscape. The report concludes with insights into the expected future prevalence of DTP programs across the industry.